News archive

15 December 2015
Result of AGM

15 December 2015
CHK1 Clinical Trial Applications

13 November 2015
Notice of AGM

26 October 2015
Final Results

15 September 2015
US and European Patent Grants for Aurora+FLT3

23 July 2015
CHK1 Research Update

17 June 2015
FUNDING AWARD FROM INNOVATE UK

28 May 2015
Placing

21 May 2015
Sareum Launches New Website

12 May 2015
Sareum to Present at BioTrinity 2015

07 May 2015
Early Conclusion of Equity Swap Agreement

16 March 2015
Change of Adviser

25 February 2015
Research & Co-Development Collaborations Update

25 February 2015
Half-yearly Report

20 January 2015
Further US Patent Grant for Sareum’s Kinase Inhibitors

17 December 2014
Result of Annual General Meeting

04 December 2014
Chinese Patent Grant for Sareum’s Kinase Inhibitors

26 November 2014
Issue of Options

10 November 2014
Notice of AGM

10 November 2014
First Patent Grant for Sareum’s TYK2 Kinase Inhibitor Programme

14 October 2014
Final Results

13 October 2014
Holding(s) in Company

01 October 2014
Promising Step in Psoriasis Drug Development

22 September 2014
CHK1 Patent Update

19 September 2014
Holding(s) In Company

11 July 2014
Holding(s) In Company

02 July 2014
Japanese Patent Grant for Sareum’s Kinase Inhibitors

30 June 2014
Total Voting Rights

26 June 2014
Preclinical Proof of Concept in TYK2 Programme

13 June 2014
Issue of Equity

26 February 2014
Research Update & Co-Development Collaborations

26 February 2014
Half-yearly Report

22 January 2014
CHK1 Patent Update

19 December 2013
Issue of Options

11 December 2013
Result of Annual General Meeting

02 December 2013
Co-Cevelopment Agreement in China for Aurora+FLT3

29 November 2013
Total Voting Rights

13 November 2013
Notice of AGM

01 November 2013
Placing to Raise £1.67 Million

25 October 2013
Sareum Presentations

10 October 2013
Final Results

24 September 2013
Sareum Enters Agreement to Advance Chk1 Programme

12 August 2013
Trading Statement

15 July 2013
Selection for Preclinical Candidate

15 July 2013
Selection for Preclinical Candidate

10 May 2013
Total Voting Rights

24 April 2013
Sareum Notified of Grant Award

22 April 2013
Sareum and SRI International Announce Co-development Agreement

25 March 2013
Issue of Equity

19 March 2013
Adviser Change of Name

18 February 2013
Half-Yearly Report

18 February 2013
Research Update

07 February 2013
US Patent Grant

04 February 2013
Notice of Results

30 January 2012
Notice of Results

27 February 2012
Research Update

27 February 2012
Half-Yearly Report

13 March 2012
Issue of Options & Transfer of Shares

06 June 2012
Placing

07 June 2012
Placing

29 June 2012
Total Voting Rights

19 July 2012
Trading Update

07 August 2012
Statement re Share Price Movement

10 September 2012
Financing

03 October 2012
Final Results

06 November 2012
Statement re Share Price Movement

13 November 2012
Availability of Report and Accounts

14 November 2012
Notice of AGM

05 December 2012
Issue of Equity

12 December 2012
Result of AGM

12 December 2012
Annual General Meeting Statement

31 December 2012
Total Voting Rights

14 December 2011
Result of AGM

11 November 2011
Sareum to Present at International Conference

04 November 2011
Report & Accounts & Notice of AGM Available

26 September 2011
Final Results

14 September 2011
Sareum to Present at European Cancer Conference

15 August 2011
Chk1 Candidate Nomination

23 May 2011
Website Update

12 May 2011
Sareum to Present at Oncology Leadership Meeting

07 March 2011
Director/PDMR Shareholding

04 March 2011
Research Update: Positive Chk1 Programme Model Studies

28 February 2011
Total Voting Rights

21 February 2011
Half-yearly Report

10 February 2011
Issue of Equity

09 February 2011
Statement re Share Price Movement

07 February 2011
Research Update

31 December 2010
Total Voting Rights

22 December 2010
Issue of Options

15 December 2010
Result of AGM

13 December 2010
Placing & Trading Update

02 December 2010
Holding(s) in Company

25 October 2010
Sareum to Present at IDDST 2010, China

22 October 2010
Final Results

09 September 2010
Holdings in Company

02 September 2010
Holdings in Company

31 August 2010
Total Voting Rights

03 August 2010
Issue of Equity

12 July 2010
NOMAD Change of Name

23 June 2010
Sareum to Present at EPIC 2010

05 May 2010
Sareum to Present at BIO 2010

26 April 2010
Scientific Advisory Board Appointment

16 March 2010
Collaboration Agreement

16 February 2010
Half Yearly Report

20 January 2010
The ICR, Sareum and CRT

16 December 2009
Result of AGM

04 December 2009
Issue of Options

24 November 2009
Holdings in Company

20 November 2009
Availability of Report & Accounts

02 November 2009
Sareum to Present at BIO-Europe 2009

30 October 2009
Total Voting Rights

27 October 2009
Final Results

19 October 2009
Holding(s) in Company

19 October 2009
NOMAD - Change of Name

15 October 2009
Holding(s) in Company

12 October 2009
Issue of Equity

09 October 2009
Holding(s) in Company

06 October 2009
Cancer Research Programme to be Presented

30 September 2009
Total Voting Rights

21 September 2009
Holding(s) in Company

16 September 2009
Holding(s) in Company

10 September 2009
Holding(s) in Company

08 September 2009
Issue of Equity

03 September 2009
Holdings in Company

28 August 2009
Statement regarding share price movement

05 June 2009
Statement re. Bulletin Board speculation

24 April 2009
Holding(s) in Company

20 April 2009
Holding(s) in Company

23 March 2009
Statement re Share Price Movement

23 March 2009
Holding(s) in Company

23 February 2009
Half Yearly Report

13 February 2009
Holding(s) in Company

27 January 2009
Result of AGM

13 January 2009
Change of registered office

22 December 2008
Restoration of Trading on AIM and Change of Adviser

22 December 2008
Publication of Report & Accounts

27 November 2008
Final Results

16 September 2008
End of Offer Period

29 August 2008
Resignation of Director, Update on Strategic Review

26 August 2008
Disposal of Assets

11 July 2008
Directorate Change

09 July 2008
Statement re. Suspension

01 July 2008
Directorate Change

26 June 2008
Change of Broker

25 June 2008
Three Repeat Business Agreements

19 June 2008
Corporate Update

14 May 2008
Restructuring

02 May 2008
Strategic Review

24 April 2008
Notification of Shareholder Interest

14 April 2008
Fundraising

10 April 2008
Sareum to Present at AACR Annual Meeting

31 March 2008
Extension of Johnson & Johnson Agreement

06 March 2008
Research Update

06 March 2008
Financial Results

04 February 2008
Notice of Results

12 December 2007
Extension of Genentech Agreement

30 November 2007
Total Voting Rights

19 November 2007
Director/PDMR Shareholding

15 November 2007
AGM Statement

15 November 2007
Placing of Shares

15 November 2007
Non-Executive Director Appointment

31 October 2007
Total Voting Rights

26 October 2007
Director/PDMR Shareholding

24 October 2007
Placing of Shares

22 October 2007
Fundraising

21 October 2007
Board Changes

16 October 2007
Annual Report and AGM Notice

08 October 2007
Holding(s) in Company

02 October 2007
Research Update

02 October 2007
Annual Results 2007

13 September 2007
Notice of Results

16 August 2007
Disclosure of Information

30 July 2007
Collaboration Extension with H. Lundbeck A/S

18 June 2007
Directorate Change

15 May 2007
Cancer Program Update

06 February 2007
Financial Results

06 February 2007
Progression of Checkpoint Kinase 1 Drug Discovery Programme

31 January 2007
Total Voting Rights

22 January 2007
Sareum To Collaborate With Johnson & Johnson

11 January 2007
Notice of Interim Results and R&D Update

08 January 2007
New Investment in Sareum

18 December 2006
Total Voting Rights

20 November 2006
Multi-Target Genentech Agreement

30 October 2006
Sareum Issue of Equity

19 October 2006
AGM Statement

19 October 2006
Board Change

09 October 2006
Research Collaboration with PIramed Ltd

26 September 2006
Cancer Collaboration with Roche

25 September 2006
Sareum Posting of Accounts

04 September 2006
Annual Results 2006

31 August 2006
Novel Compounds Discovered In Cancer Drug Discovery Collaboration

15 August 2006
Second Collaboration with Lundbeck A/S

13 July 2006
Extension of Collaboration with Almirall Prodesfarma S.A.

20 June 2006
Collaboration with Sirtris Pharmaceuticals

14 June 2006
Sareum Holding(s) in Company

08 June 2006
Success Milestones Reached in Collaboration with Schering AG

23 February 2006
Financial Results

09 February 2006
$5M Research Collaboration with Idenix Pharmaceuticals, Inc.

26 January 2006
Crystal Bank Collaboration with UCB

19 January 2006
Sareum Announce Collaboration with Lundbeck A/S

17 January 2006
Organon & Sareum Announce Research Collaboration in Autoimmune Disease

12 January 2006
BCL-2, an Important Oncology Protein Structure, added to Crystal Bank

10 January 2006
Collaboration with Idenix Pharmaceuticals, Inc.

05 January 2006
Trading Update

13 December 2005
Collaboration with Karus Therapeutics

24 November 2005
Crystal Bank update

27 October 2005
Collaboration with Schering AG

10 October 2005
Annual report 2005

22 September 2005
Collaboration with Infinity Pharmaceuticals, Inc

19 September 2005
Annual results 2005

01 September 2005
Launch of Crystal Bank to Accelerate Structure Based Drug Discovery

10 August 2005
Collaboration with Leading Spanish Pharmaceutical Company Almirall Prodesfarma S.A.

25 July 2005
Major Cancer Drug Discovery

30 June 2005
Success Milestone

13 May 2005
Sareum & Rigaku

25 April 2005
Offer Discussions

11 April 2005
Cancer Research Technology

29 March 2005
Financial Results

04 March 2005
Statement regarding

15 December 2004
UK Pharmaceutical Company

06 December 2004
Cancer Research Technology

01 December 2004
Sareum & EiRx

22 November 2004
Millennium Pharmaceuticals

09 November 2004
Inpharmatica Collaboration

11 October 2004
Sareum Admission to AIM

15 September 2004
Board Appointments